Valeant avoids double-digit price hikes with 9.9 percent increases
(By Ed Silverman for STAT) In response to intensifying criticism over drug prices, Allergan chief executive Brent Saunders promised1 not
Read More
Part D/Prescription Drugs
Colorado is latest state to be sued for restricting access to hepatitis C drugs
(By Ed Silverman for STAT) You can add Colorado to the list of states being sued1 for refusing to widen
Read MoreSecret trove reveals bold ‘crusade’ to make OxyContin a blockbuster
(By David Armstrong for STAT) WELCH, W.Va. — The pharmaceutical sales representatives from health care giant Abbott Laboratories had a problem.
Read MoreWorld leaders pledge to tackle superbugs, but set no specific targets
(By Helen Branswell for STAT) Countries from around the world agreed Wednesday to take concerted efforts to tackle the growing
Read MoreMylan CEO Claims EpiPens Aren’t As Profitable As Everyone Thinks
(By Alison Kodjak for NPR) The drug company that makes the EpiPen says it isn’t nearly as profitable as many
Read MoreHow Much Has Medicare Spent on the EpiPen Since 2007?
(By Juiette Cubanski, Tricia Neuman, and Anthony Damico for Kaiser Family Foundation) The latest example of high and rising prescription
Read MoreVeterans Courted In California’s Ballot Fight Over Curbing Drug Prices
(By Pauline Bartolone for California Healthline) Once a month at the Veterans of Foreign Wars building in Sacramento, a couple
Read MoreCalifornia governor decries ‘predatory’ pricing as he signs law to make EpiPen available
(By Ed Silverman for STAT) For all intents and purposes, California Governor Jerry Brown held his nose Friday as he
Read MoreSarepta to charge $300K for Duchenne drug. ‘We tried to be reasonable,’ CEO says
(By Ed Silverman for STAT) The newly approved1 Sarepta Therapeutics drug for Duchenne muscular dystrophy2 will cost about $300,000 a
Read MoreAs profitable fentanyl industry expands in China, US negotiates to halt the deadly trade
(By Kathleen McLaughlin for STAT) BEIJING — Top American and Chinese enforcement officials are negotiating how to fight the rampant
Read More